ARCUS BIOSCIENCES INC (RCUS) Stock Analyst Earnings Estimates
NYSE:RCUS - New York Stock Exchange, Inc. - US03969F1093 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 382.9M 394.06% | 112M -70.75% | 117M 4.46% | 266.35M 127.65% | 215.79M -18.98% | 227.9M 5.61% | 285.73M 25.38% | 650.76M 127.75% | 959.86M 47.50% | 1.328B 38.35% | 1.385B 4.29% | 1.573B 13.57% | |
| EBITDA YoY % growth | 58M 147.89% | -274M -572.41% | -332M -21.17% | -314.722M 5.20% | -321.531M -2.16% | -463.575M -44.18% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 54.2M 143.64% | -280M -616.61% | -340M -21.43% | -341.713M -0.50% | -429.816M -25.78% | -468.504M -9.00% | -487.035M -3.96% | -128.061M 73.71% | 185.24M 244.65% | 505.21M 172.73% | 716.74M 41.87% | 880.48M 22.85% | |
| Operating Margin | 14.16% | -250.00% | -290.60% | -128.29% | -199.18% | -205.57% | -170.45% | -19.68% | 19.30% | 38.04% | 51.75% | 55.97% | |
| EPS YoY % growth | 0.43 118.30% | -3.72 -965.12% | -4.15 -11.56% | -3.47 16.46% | -4.70 -35.48% | -4.42 5.95% | -4.71 -6.52% | -2.22 52.75% | -1.27 42.81% | 1.32 204.01% | 4.11 210.40% | 4.72 15.03% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.27 -17.94% | -1.22 -2,337.80% | -1.26 -23.75% | -1.29 -28.77% | -1.35 -6.24% | -1.32 -8.54% | -1.29 -2.14% | -1.32 -2.34% | -1.34 1.18% | -1.37 -3.86% | -1.27 1.42% | -1.15 12.62% |
| Revenue Q2Q % growth | 29.478M -4.91% | 43.35M -70.10% | 40.8M 4.62% | 40.8M -15.00% | 39.1M 32.64% | 25.5M -41.18% | 25.5M -37.50% | 25.5M -37.50% | 25.5M -34.78% | 26.73M 4.82% | 36.141M 41.73% | 53.019M 107.92% |
| EBITDA Q2Q % growth | -112.948M -36.08% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -124.426M -36.73% | -116.79M -3,019.75% | -122.4M -15.47% | -124.95M -19.00% | -136.68M -9.85% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -1.00 -6.38% | -1.08 | 0.08 | 7.78% |
| Q2 2024 Q2Q % growth | -1.02 1.92% | -1.12 | 0.10 | 8.92% |
| Q1 2024 Q2Q % growth | -0.05 95.41% | -0.97 | 0.92 | 94.85% |
| Q4 2023 Q2Q % growth | -1.08 -16.13% | -1.04 | -0.04 | -3.39% |
| Q3 2023 Q2Q % growth | -0.94 -4.44% | -1.15 | 0.21 | 18.35% |
| Q2 2023 Q2Q % growth | -1.04 -11.83% | -1.12 | 0.08 | 7.19% |
| Q1 2023 Q2Q % growth | -1.09 -13.54% | -1.19 | 0.10 | 8.14% |
| Q4 2022 Q2Q % growth | -0.93 -125.07% | -1.09 | 0.16 | 14.53% |
| Q3 2022 Q2Q % growth | -0.90 18.92% | -1.06 | 0.16 | 14.99% |
| Q2 2022 Q2Q % growth | -0.93 14.68% | -0.96 | 0.03 | 3.18% |
| Q1 2022 Q2Q % growth | -0.96 11.11% | -0.88 | -0.08 | -9.30% |
| Q4 2021 Q2Q % growth | 3.71 552.44% | -0.76 | 4.47 | 589.04% |
| Q3 2021 Q2Q % growth | -1.11 -3,800.00% | -1.10 | -0.01 | -1.15% |
| Q2 2021 Q2Q % growth | -1.09 -17.20% | -0.89 | -0.20 | -22.28% |
| Q1 2021 Q2Q % growth | -1.08 -71.43% | -0.84 | -0.24 | -27.86% |
| Q4 2020 Q2Q % growth | -0.82 -115.79% | -0.76 | -0.06 | -7.29% |
| Q3 2020 Q2Q % growth | 0.03 105.88% | 0.05 | -0.02 | -41.18% |
| Q2 2020 Q2Q % growth | -0.93 -45.31% | -0.62 | -0.31 | -49.04% |
| Q1 2020 Q2Q % growth | -0.63 -53.66% | -0.58 | -0.05 | -9.44% |
| Q4 2019 Q2Q % growth | -0.38 | -0.52 | 0.14 | 26.77% |
| Q3 2019 Q2Q % growth | -0.51 | -0.50 | -0.01 | -2.92% |
| Q2 2019 Q2Q % growth | -0.64 | -0.41 | -0.23 | -55.31% |
| Q1 2019 Q2Q % growth | -0.41 | -0.36 | -0.05 | -14.60% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 48M 50.00% | 38.307M | 9.693M | 25.30% |
| Q2 2024 Q2Q % growth | 39M 34.48% | 26.125M | 12.875M | 49.28% |
| Q1 2024 Q2Q % growth | 145M 480.00% | 34.54M | 110.46M | 319.80% |
| Q4 2023 Q2Q % growth | 31M -8.01% | 28.935M | 2.065M | 7.14% |
| Q3 2023 Q2Q % growth | 32M -4.76% | 27.828M | 4.172M | 14.99% |
| Q2 2023 Q2Q % growth | 29M 8.21% | 30.904M | -1.904M | -6.16% |
| Q1 2023 Q2Q % growth | 25M 38.89% | 25.467M | -467K | -1.83% |
| Q4 2022 Q2Q % growth | 33.7M -90.49% | 23.773M | 9.927M | 41.76% |
| Q3 2022 Q2Q % growth | 33.6M 253.68% | 22.325M | 11.275M | 50.50% |
| Q2 2022 Q2Q % growth | 26.8M 182.11% | 21.548M | 5.252M | 24.37% |
| Q1 2022 Q2Q % growth | 18M 89.47% | 27.158M | -9.158M | -33.72% |
| Q4 2021 Q2Q % growth | 354.5M 3,631.58% | 40.175M | 314.325M | 782.39% |
| Q3 2021 Q2Q % growth | 9.5M -85.27% | 9.588M | -88K | -0.92% |
| Q2 2021 Q2Q % growth | 9.5M 427.78% | 13.316M | -3.816M | -28.66% |
| Q1 2021 Q2Q % growth | 9.5M 427.78% | 12.49M | -2.99M | -23.94% |
| Q4 2020 Q2Q % growth | 9.5M -3.06% | 8.087M | 1.413M | 17.47% |
| Q3 2020 Q2Q % growth | 64.5M 3,483.33% | 49.113M | 15.387M | 31.33% |
| Q2 2020 Q2Q % growth | 1.8M | 1.664M | 136K | 8.17% |
| Q1 2020 Q2Q % growth | 1.8M | 1.562M | 238K | 15.24% |
| Q4 2019 Q2Q % growth | 9.8M | 1.588M | 8.212M | 517.13% |
| Q3 2019 Q2Q % growth | 1.8M | 1.567M | 233K | 14.87% |
| Q2 2019 Q2Q % growth | 1.8M | 3.413M | -1.613M | -47.26% |
| Q1 2019 Q2Q % growth | 1.8M | 1.649M | 151K | 9.16% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.26% | -5.29% | 0% | -2.51% |
| Revenue | 0% | -3.23% | 0% | 6.89% |